Research Analysts’ Updated EPS Estimates for September 5th (AAPL, AI, APLD, BASE, CHPT, CHRD, CXM, DKS, DOCU, ELV)

Research Analysts’ updated eps estimates for Thursday, September 5th:

Apple (NASDAQ:AAPL) had its buy rating reissued by analysts at Bank of America Co.. Bank of America Co. currently has a $256.00 price target on the stock.

C3.ai (NYSE:AI) had its outperform rating reiterated by analysts at Oppenheimer Holdings Inc.. They currently have a $40.00 target price on the stock.

C3.ai (NYSE:AI) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $40.00 price target on the stock.

Applied Digital (NASDAQ:APLD) had its buy rating reiterated by analysts at Roth Mkm. They currently have a $10.00 target price on the stock.

Couchbase (NASDAQ:BASE) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $25.00 target price on the stock.

ChargePoint (NYSE:CHPT) had its buy rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $3.00 price target on the stock.

Chord Energy (NASDAQ:CHRD) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $200.00 target price on the stock.

Sprinklr (NYSE:CXM) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $17.00 price target on the stock.

DICK’S Sporting Goods (NYSE:DKS) had its outperform rating reissued by analysts at Evercore ISI. Evercore ISI currently has a $280.00 target price on the stock.

DocuSign (NASDAQ:DOCU) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $84.00 target price on the stock.

Elevance Health (NYSE:ELV) had its overweight rating reaffirmed by analysts at Stephens. The firm currently has a $615.00 target price on the stock.

Shift4 Payments (NYSE:FOUR) had its buy rating reiterated by analysts at Benchmark Co.. The firm currently has a $99.00 target price on the stock.

Fortive (NYSE:FTV) was upgraded by analysts at Raymond James from a market perform rating to an outperform rating. They currently have $85.00 price target on the stock.

Frontier Communications Parent (NASDAQ:FYBR) had its buy rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $37.00 target price on the stock.

Humacyte (NASDAQ:HUMA) had its buy rating reiterated by analysts at Benchmark Co.. Benchmark Co. currently has a $15.00 price target on the stock.

Coca-Cola (NYSE:KO) had its hold rating reissued by analysts at Cfra.

NVIDIA (NASDAQ:NVDA) had its buy rating reaffirmed by analysts at Bank of America Co.. Bank of America Co. currently has a $165.00 target price on the stock.

Old Dominion Freight Line (NASDAQ:ODFL) had its hold rating reaffirmed by analysts at Benchmark Co..

Old Dominion Freight Line (NASDAQ:ODFL) had its overweight rating reiterated by analysts at Stephens. They currently have a $214.00 price target on the stock.

Phreesia (NYSE:PHR) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $23.00 target price on the stock.

Phreesia (NYSE:PHR) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $30.00 price target on the stock.

Regeneron Pharmaceuticals (NASDAQ:REGN) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $1,250.00 target price on the stock.

Saia (NASDAQ:SAIA) had its buy rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $480.00 target price on the stock.

Tesla (NASDAQ:TSLA) had its overweight rating reiterated by analysts at Morgan Stanley. The firm currently has a $310.00 price target on the stock.

Verint Systems (NASDAQ:VRNT) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $36.00 price target on the stock.

XPO (NYSE:XPO) had its overweight rating reissued by analysts at Stephens. Stephens currently has a $150.00 target price on the stock.

Zimmer Biomet (NYSE:ZBH) had its hold rating reissued by analysts at Truist Financial Co.. They currently have a $117.00 price target on the stock.

Zimmer Biomet (NYSE:ZBH) had its in-line rating reaffirmed by analysts at Evercore ISI. Evercore ISI currently has a $113.00 price target on the stock.